Nisa Investment Advisors LLC Has $22.46 Million Position in CVS Health Corporation (NYSE:CVS)

Nisa Investment Advisors LLC lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 8.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,498 shares of the pharmacy operator’s stock after acquiring an additional 26,981 shares during the quarter. Nisa Investment Advisors LLC’s holdings in CVS Health were worth $22,459,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in CVS. Hopwood Financial Services Inc. acquired a new position in shares of CVS Health in the 4th quarter worth approximately $29,000. McIlrath & Eck LLC raised its stake in CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 174 shares during the last quarter. Park Square Financial Group LLC bought a new stake in CVS Health during the fourth quarter valued at $43,000. PARK CIRCLE Co grew its holdings in CVS Health by 42.9% during the 4th quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator’s stock worth $45,000 after acquiring an additional 300 shares during the period. Finally, Strategic Investment Solutions Inc. IL lifted its stake in shares of CVS Health by 77.2% in the 4th quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator’s stock valued at $46,000 after purchasing an additional 446 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CVS has been the subject of several recent analyst reports. Mizuho raised their price objective on shares of CVS Health from $70.00 to $76.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. UBS Group raised their price objective on CVS Health from $67.00 to $71.00 and gave the company a “neutral” rating in a research note on Friday, May 2nd. Cowen reissued a “buy” rating on shares of CVS Health in a research report on Monday, May 5th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and set a $84.00 target price (up previously from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $75.06.

CVS Health Stock Down 0.4%

CVS stock opened at $66.65 on Thursday. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The firm has a market capitalization of $84.31 billion, a PE ratio of 15.91, a PEG ratio of 0.96 and a beta of 0.57. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. The stock has a 50-day simple moving average of $65.18 and a two-hundred day simple moving average of $61.93.

CVS Health (NYSE:CVS) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. CVS Health’s revenue was up 7.0% on a year-over-year basis. On average, equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.99%. The ex-dividend date of this dividend is Tuesday, July 22nd. CVS Health’s dividend payout ratio is 63.48%.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone purchased 1,570 shares of the stock in a transaction on Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the acquisition, the director directly owned 12,007 shares in the company, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.22% of the stock is currently owned by insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.